Fifteen years ago, Project BioShield was created to enhance this nation’s health security by providing unique authorities and dedicated funds to help us develop and purchase medical countermeasures, especially those with limited commercial value. In the last decade and a half, Project BioShield received appropriations of more than $8.6 billion, and has supported 27 medical countermeasure development and acquisition projects; 15 of those products have been added to the Strategic National Stockpile.

FDA Clears First Medical Product in
U.S. for Use on Certain Injuries
Caused by Sulfur Mustard

Mark Your Calendar: BARDA Industry
Day to be Held October 15-16 2019;
Online Registration Coming Soon

Online Participation Still Available for
ASPR Next Innovation Day, Aug 7-8;
New Program Designed to Spur
Innovation in the Development of
New Products for Use in Disasters

ASPR Collaborates with DoD,
VenatoRx Pharmaceuticals on
Novel Antibiotic to Treat Infections
Caused by Bacteria Resistant to
Currently Available Agents

ASPR Sponsors Development of
SpectralMD’s Portable, User-friendly
Imaging Device to Evaluate the
Depth & Severity of Burn Injuries

BARDA DRIVe Partners with Evidation
on Using Data Generated by Wearable
Devices to Predict Respiratory
Infections & Exposures to Pathogens

Redefining How We Think of
Disaster Preparedness:
The Health Care Coalition Response
Leadership Course

Mass Casualty Trauma Triage: Learn
the Differences between Conventional
Mass Casualty Incidents and
Mass Violence Events